Relugolix combination therapy in symptomatic adenomyosis and uterine fibroids: a case series
Objective To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids.Methods This case series included six women with uterine fib...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2026-12-01
|
| Serie: | Gynecological Endocrinology |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/09513590.2026.2659439 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|